Author

Kseniya Yu. Vlasova

Oregon State UniversityORCID 0000-0003-3774-1323Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 1 Organism:mouse· 1 Assay:multiome· 1

Frequent Co-Authors

A. Kerr· 1 shared A. Roberts· 1 shared Anitha M. Thomas· 1 shared Antony JozićiD· 1 shared Avisek Deyati· 1 shared Daniel Arriaza· 1 shared Deepak Kumar SaheliD· 1 shared Essam Helmy· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. Kerr

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringbioRxivPreprintApr 15, 2026

Lipid Nanoparticles for Spleen-Targeted RNA delivery

Kseniya Yu. Vlasova, Noorjahan Aibani, Mrinmoy Sanyal…·Howard Y. Chang

This study develops lipid nanoparticles (LNPs) for spleen-targeted RNA delivery without altering charge, showing improved splenic accumulation and distinct transcriptomic effects compared to conventional LNPs.

DOI 10.64898/2026.04.13.718229

humanexperimental assay

𝕏 PostBluesky

BioengineeringNature CommunicationsPeer-reviewedApr 29, 2025

Synthesis of ionizable lipopolymers using split-Ugi reaction for pulmonary delivery of various size RNAs and gene editing

Kseniya Yu. Vlasova, A. Kerr, Nathan D. Pennock…·Gaurav Sahay

The paper develops a method to deliver various RNA therapeutics, including mRNA and CRISPR-Cas9, to the lung using lipopolymer-lipid hybrid nanoparticles, showing improved efficacy and reduced toxicity.

35 citationstop 1%

mousemultiome

𝕏 PostBluesky